| |
Learning Center
Hemostasis Happenings
Tuesday, September 1, 2009
HEMOSTASIS HAPPENINGS: SEPTEMBER 2009
HEMOSTASIS HAPPENINGS: SEPTEMBER 2009
Member Society ASCLS Region VIII
Dates September 16-19, 2009
Meeting Intermountain States Seminar - Teton Mountain Mystery
Sponsors ASCLS-Colorado - Host Society
Name J.R. Constance, Publicity Co-Chair
URL http://imss.asclsregionviii.org
Email jrc@rodricon.com
Phone 720-339-3646
Hotel Snow King Lodge
City Jackson Hole
State WY
Diagnosis of Antiphospholipid Syndrome: Michael Nardi, Thursday September 17th
Thursday 24 September 2009
0730-0830
Christian Medical Fellowship Breakfast
0730-0900
Schering-Plough Breakfast Satellite Symposium
Sugammadex in anaesthetic practice: Clinical experience
and issues from the first year
0900-1030
Session 5
A: Association of Paediatric Anaesthesists
Stabilisation and transfer of sick children
Dr Sabeena Qureshi, London
Loco-regional techniques for children
Dr Steve Roberts, Liverpool
Paediatric neurosurgery: Where are we in 2009?
Mr Paul May, Liverpool
B: Focus on the heart
Protecting the heart in the peri-operative period
Dr Peter Noordzij, Rotterdam
What to do about stents and antithrombotics?
Dr Paul Erasmus, Plymouth
A practical approach to patients with valvular disease
Dr Richard Struthers, Plymouth
________________________________________
17th Annual Symposium on New Advances in Blood Management
Westin Crown Center Hotel
Kansas City, Missouri
October 1-3, 2009
MEETING ANNOUNCEMENT
The American Society of ExtraCorporeal Technology is proud to announce the 17th Annual Symposium on New Advances in Blood Management. The meeting is dedicated to presenting the latest information on the field of perioperative blood management and its impact on patient care.
Major subject areas for the meeting include the following:
- Blood Management in Cardiac Thoracic and Vascular Surgery
- Minimizing Bleeding and Allogeneic Blood Transfusion Exposure
- The Role of Extracorporeal Interventions on Optimizing Perfusion and the Improvement of Cardiopulmonary Bypass
- Advances in Coagulation Monitoring: Present and the Future
- Mechanisms of Reducing Inflammation during Cardiopulmonary Bypass
- Autologous Platelet Harvesting and its Applications
Each session will have a minimum of three scientific sessions followed by a question and answer session. Speakers have been chosen who reflect the current state-of-the-art for all content areas and will report on both the physiological aspects of their subjects and on clinical studies. Emphasis will be placed on those interventions that have been scientifically shown, through techniques of evidenced-based medicine, to promote enhanced patient outcome.
This year the meeting will be held from October 1-3, 2009 at the Westin Crown Center in Kansas City, Missouri. Registration information can be obtained below.
The BBTS 27th Annual Conference
Manchester 10th - 12th September 2009
Manchester Central, Manchester
The BBTS Annual Conference for 2009 continues the theme from 2008 of providing an invigorating mix of topics from research in the blood centre to practical bedside transfusion. Plenary sessions include managing blood supply in both the developed and the less developed world, transfusion policies in major trauma; civilian and military including problems with ABO blood groups in transplantation and malaria. Parallel sessions range from the latest applications of genetics and stem cell culture to practical aspects of paediatric and platelet transfusion. The meeting should provide something for everyone with an interest in transfusion with many exciting talks by leaders and experts in the field. The conference will be held in the centre of Manchester and the social programme promises to make best use of the active night life of this bustling city!
Dr Jonathan Wallis, Chair of Scientific Meeting Administration Committee.
Booking is available now online!
Session 1 - Introduction
10.00 Welcome
Introduction on hemostasis
Marcel Levi
Hemostatic defects in patients with liver
disease
Peter Witters
Compensatory hemostatic mechanisms in
patients with liver disease
Ton Lisman
Discussion
12.00 Lunch
Session 2 - Effect of liver disease on coagulation
Part 1: Bleeding
13.00 Evidence for coagulopathy in patients with cirrhosis
Francesco Violi
Variceal bleeding - a role for the hemostatic system?
Marco Senzolo
Bleeding in acute liver failure
Todd Stravitz
Link between infection and coagulation in patients
with cirrhosis
Andrew Burroughs
Managing platelets in hepatitis C
Carl Berg
Discussion
15.30 Break
Part 2: Thrombosis
16.00 Hypercoagulation and thrombosis in patients
with cirrhosis
Patrick Northup
Budd Chiari Syndrome and portal vein thrombosis
Harry Janssen
Hypercoagulation and NASH
Arun Sanyal
Anticoagulation in the NASH patient with
coronary artery disease and liver failure
Stephen Caldwell
Anticoagulant therapy in patients with cirrhosis
Dominique Valla
Discussion
18.30 Conference dinner
08.00 Reception with coffee
Session 3 - Effect of the coagulation system
on the liver
08:30 The role of hypercoagulation in the patho-
genesis of liver fi brosis
Quentin Anstee
The role of platelet-derived serotonin in the
liver disease and regeneration
Pierre-Alain Clavien
Discussion
09.45 Break
Session 4 - Advances and pitfalls in laboratory
testing
10.15 Limitations of routine laboratory tests of
hemostasis
Philip de Groot
Novel global tests of hemostasis and its value
in liver disease
Armando Tripodi
The INR and the MELD score:
are we making progress?
James Trotter
Discussion
12.00 Lunch
Saturday 19 September 2009
Session 5 - Management of coagulation
disorders in patients with liver disease
13.00 Coagulation management in cirrhotic patients
undergoing minor invasive procedures
Frank Leebeek
Use of plasma concentrates during small
invasive procedures in patients with cirrhosis
Pratima Chowdary
Adverse effects of blood products
Joost de Wolf
The role of pharmacological agents to control
bleeding in cirrhotic patients
Jerrold Levy
15.00 Break
15.30 Fluid restriction as a method to control bleeding
in cirrhotic patients undergoing major surgical
procedures
Robert Porte
The role of topical hemostatic agents in liver
surgery
Marieke de Boer
Treatment and prevention of thrombosis in
patients with liver disease
Marco Vivarelli
Discussion
Session 6 - Future perspectives
17.00 Keynote & wrap-up lecture
Stephen Caldwell
18.00 Closing
Drinks
programma.indd 2 19-03-09 11:39
Cytopenias and Hemostasis in 2009
Orlando Florida Sept 23-25
7:00-9:00 pm Dinner
Day 1 24 September 2009
7:00-7:50 am Breakfast
Session I: Clonal thrombocytopenias
8:00-8:25 Platelet production
Joseph E. Italiano, PhD
8:25-8:50 Paroxysmal nocturnal hemoglobinuria
Neal S. Young, MD
8:50-9:15 Myelodysplastic syndrome
David R. Head, MD
9:15-9:40 Jak2/Stat
Jerry L. Spivak, MD
9:40-10:05 Myelofibrosis
Ross L. Levine, MD
10:05-10:30 Lessons learned from rodent models on mechanisms of treatment of ITP
Alan A. Lazarus, PhD
10:30-10:45 Break
Session II: Immune thrombocytopenia
10:45-11:10 Animal models of ITP: Immunopathogenesis leading to platelet and bone marrow destruction
John W. Semple, PhD
11:10-11:35 Platelet production in ITP
David J. Kuter, MD, PhD
11:35-12:00 pm Controversies in ITP
Douglas B. Cines, MD
12:00-12:25 Platelet function and bleeding in ITP
Alan D. Michelson, MD
12:25-12:50 TPO-like agents
James B. Bussel, MD
12:50-1:15 Management of secondary ITP
Howard A. Liebman, MD
1:15-2:15 Lunch
2:15-2:20 Introduction to Wendell F. Rosse, MD
Douglas B. Cines, MD
2:20-3:10 Keynote Address
Wendell F. Rosse, MD
3:10-4:00 Poster review with authors attending
4:00 Break for day
Day 2 25 September 2009
7:00-7:50 am Breakfast
Session III: Thrombotic thrombocytopenias
8:00-8:25 Platelet-platelet, platelet-vessel wall interactions
Andrew S. Weyrich, PhD
8:25-8:50 Platelet polymorphisms
Paul F. Bray, MD
8:50-9:15 Hypercoagulation workup
Kenneth A. Bauer, MD
9:15-9:40 Thrombocytopenias and vasculitis in pregnancy
Keith R. McCrae, MD
9:40-10:05 Heparin-induced thrombocytopenia
Gowthami M. Arepally, MD
10:05-10:20 Break
Session IV: Other Platelet Disorders
10:20-10:45 The molecular control of platelet lifespan
Benjamin T. Kile, LLB, PhD
10:45-11:10 A mouse model to evaluate human platelet function and drug therapies
Thomas G. Diacovo, MD
11:10-11:35 Microparticles
Nigel S. Key, MB, ChB
11:35-12:00 pm Thrombotic thrombocytopenic purpura
David Motto, MD, PhD
12:00-12:25 ADAMTS13
X. Long Zheng, MD, PhD
12:25-12:50 Transfusion-related acute lung injury
Don L. Siegel, MD, PhD
12:50-1:50 Lunch
1:50-2:00 Introduction to Robert McMillan
James B. Bussel, MD
2:00-2:50 First Annual Robert McMillan Honorary Lecture
Robert McMillan, MD
Session V: Anemias
2:50-3:15 Erythropoietin-stimulating agents underutilized
John Glaspy, MD
3:15-3:40 Erythropoietin-stimulating agents overutilized
Charles L. Bennett, MD, PhD
3:40-4:05 Advances in the management of sickle cell disease
Russell E. Ware, MD, PhD
4:05-4:30 Autoimmune hemolytic anemia
Howard A. Liebman, MD
4:30 Break for day
Day 3 26 September 2009
7:00-7:50 am Breakfast
Session VI: Coagulopathies
8:00-8:25 von Willebrand disease
Gilbert C. White II, MD
8:25-8:50 New anticoagulants
Jeffrey I. Weitz, MD
8:50-9:15 Activation markers of coagulation
Craig M. Kessler, MD
9:15-9:40 Hemophilia with inhibitors—New developments
Donna M. DiMichele, MD
9:40-10:05 Use/misuse of rVII
Bruce S. Sachais, MD, PhD
10:05-10:20 Break
Select clinical discussions and presentations
10:20-10:40 Clinical discussion 1
TBD
10:40-11:00 Clinical discussion 2
TBD
11:00-11:20 Clinical discussion 3
TBD
11:20 Meeting adjournment and Lunch
Donna Castellone
|
|
About the Author
Donna Castellone,
MS, MT(ASCP)SH
View Complete Profile
Links
Previous Posts
Archives
|
|
